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ABSTRACT
EVALUATION OF THE PREDICTIVE ABILITY OF A SCREENING
INSTRUMENT USED TO DIAGNOSE CO-OCCURRENCE OF ANXIETY IN
CHILDREN WITH HIGH-FUNCTIONING AUTISM

Austin Zachary

November 28, 2018

Anxiety has shown to have a high co-occurrence in children with Autism
Spectrum Disorder (ASD), but has been difficult to co-diagnose. This study
analyzed the ability of the Screen for Child Anxiety-Related Emotional Disorders
(SCARED) to predict positive ASD screenings of the Social Responsiveness
Scale (SRS). Parents and children ages 8 to 18 years (N = 100) were screened
for anxiety using the SCARED and autism using the SRS. Moderate correlation
was found between parent-reported SCARED and positive screening of the SRS
(r = .579), with weak correlation found in the child-reported SCARED (r = .105).
LASSO regression was conducted to assess SCARED predictability of the SRS.
Two of forty-one questions from the parent-reported SCARED significantly
predicted a positive screening of the SRS. Age was a significant predictor of this
association (OR = 1.141). The SCARED has shown significant predictability of
positive screenings on the SRS in children with autism.
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INTRODUCTION

Anxiety and Autism Spectrum Disorder (ASD) are among the most
diagnosed mental conditions in children, with a common co-occurrence of both
disorders (1). While it is known that both co-occur frequently, previous manuals
used by physicians to diagnose mental conditions have recommended against
co-diagnosis (2). This previous thought comes from the repetitiveness of
symptoms shown in children with either ASD or anxiety, along with the difficulty
of children with ASD to properly report on one’s emotions (3). Although this
thinking has evolved, there is no gold standard by which co-occurrence of both
disorders may be diagnosed in a patient. The formulation of a method of
accurately predicting anxiety in a population of children with autism will allow for
more effective treatment of both disorders.
The Screen for Child Anxiety-Related Emotional Disorders (SCARED) is a
parent- and child-reported instrument that evaluates anxiety in children. The
Social Responsiveness Scale (SRS) is a parent reported instrument that
evaluates their children for symptoms of ASD. Both the SCARED and SRS have
been used in research, but there have been gaps in the research. Although
previous studies have compared different anxiety measures to the SRS, however
the SCARED has not been critically evaluated for its predictive ability of the SRS.
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This study was conducted to evaluate associations between a scale used to
diagnose anxiety disorders (SCARED) and a scale used to diagnose ASD (SRS)
in children between the ages 8-18 years diagnosed with ASD.

Primary Objective:
To determine if the SCARED is an accurate predictor of a positive or severe
screening on the SRS in children aged 8 to 18 years of age diagnosed with ASD.

Specific Aims:
Study Aim 1:
a) To determine the correlation between the parent-reported report of anxiety
disorders (SCARED) and severity of ASD (SRS) in children with ASD.
b) To determine the correlation between the child-reported report of anxiety
disorders (SCARED) and severity of ASD (SRS) in children with ASD.

Hypothesis 1:
Both the parent and child-reported report of the SCARED will have a
positive correlation with the SRS, with the parent-reported versions having
a stronger correlation.
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Study Aim 2:
a) To evaluate the ability of the parent-reported version of the SCARED to
accurately predict a positive screening of the SRS in children with ASD.
b) To evaluate the ability of the child-reported version of the SCARED to
accurately predict a positive screening of the SRS in children with ASD.

Hypothesis 2:
Both the parent-reported and child-reported versions of the SCARED will
significantly predict the SRS.

Study Aim 3:
a) To evaluate the association between the parent-reported version of
anxiety disorders (SCARED) and the ASD (SRS) adjusting for age, sex,
and race in children with ASD.
b) To evaluate the association between the child-reported version of anxiety
disorders (SCARED) and the ASD (SRS) adjusting for age, sex, and race
in children with ASD.
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Hypothesis 3:
Age will be have a significant predictability of the association between the
SCARED and SRS. Both race and sex will not have significant
predictability of the association between the SCARED and SRS.
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BACKGROUND AND RATIONALE

Description of Conditions
ASD is diagnosed using criteria laid out in the 5th edition of the Diagnostic
and Statistical Manual of Mental Disorders (DSM-5(4)). This diagnosis is
characterized by constant impairments in social communications and
interactions, along with intellectual and language impairments.
Anxiety disorders are also diagnosed using the criteria laid out by the
DSM-5 (4). This diagnosis includes the presence of excessive anxiety and worry
about a variety of topics often for at least 6 months and causes the patient to
have noticeable psychical or cognitive symptoms, such as edginess, tiring easily,
and irritability.
Epidemiology of ASD and Anxiety Disorders in Children in the General U.S.
Population
According to the Center for Disease Control and Prevention, the
prevalence of ASD in children who are 8 years old is approximately 1 in 68 (5).
With approximately 74.2 million children living in the United States (6),
approximately 1.09 million children have been diagnosed with ASD. The
estimated prevalence is significantly higher in boys (23.6 in 1,000) than
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girls (5.3 in 1,000). Non-Hispanic White children have the highest prevalence
(15.5 per 1,000), followed by non-Hispanic Black children (13.2 per 1,000), and
finally Hispanic children (10.1 per 1,000; (5)). According to the National Institute
of Mental Health, approximately 31.9% of children ages 13 to 18 years old are
diagnosed with anxiety disorders (7). With approximately 74.2 million children
living in the United States (6), approximately 23.67 million children have been
diagnosed with anxiety disorders. Females have a higher prevalence of all
anxiety disorders when compared to males (7).
Symptoms of ASD
According to the DSM-5, ASD can be diagnosed with a variety of criteria,
including: deficits in social communication and interaction, restricted and
repetitive patterns of behavior, present in early development, clinically significant
impairment in social or occupational areas, and is not better explained by an
intellectual disability (4). According to the CDC, other symptoms include avoiding
eye contact, avoiding physical contact, obsessive tendencies, and having
delayed speech and language (8).
Symptoms of Anxiety Disorders
According to the DSM-5, anxiety disorders can be diagnosed with a
variety of criteria, including: restlessness, being easily fatigued, difficulty
concentrating, irritability, muscle tension, chronic worrying, and sleep problems
(4). Anxiety also causes children to be afraid when away from parents, extreme
fear of specific things or situations, being afraid of social situations, including
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school, and repeated episodes of sudden and intense fear that can come with
symptoms such as increased heart rate, having trouble breathing, or feeling dizzy
and shaky.
Risk Factors of Anxiety Disorders and ASD
While there is no all-inclusive hypothesis on what risk factors are
associated with anxiety, there are many that are suggested to be a possible
cause of anxiety disorders. Possible risk factors include substance abuse,
childhood traumas, stresses of everyday life, a family history of anxiety disorders,
and pre-existing medical conditions, including heart disease, diabetes, and
asthma. Most of these, however, pertain to anxiety in adults.
While there is no all-inclusive hypothesis on the causes of ASD, there are
many factors that have been suggested as causes to multiple types of ASD. Most
experts agree that genes are one of the risk factors that makes a person more
likely to develop ASD (9), along with certain genetic or chromosomal conditions,
such as fragile X syndrome (10-13) or tuberous sclerosis (10, 11, 13). Children
who are born to older parents are also at a greater risk of developing ASD (14),
along with children who have siblings with ASD (15-20). Other known risk factors
that are associated with ASD include: taking valproic acid and thalidomide during
pregnancy (21, 22), multiple births, fetal distress, low birth weight, feeding
difficulties, umbilical-cord complications, and hyperbilirubinemia (23). Children of
foreign-born Black, Filipino, and Vietnamese mothers have higher risks of
developing ASD when compared to White US-born children (24).
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There are several potential, but inconsistent risk factors for developing
anxiety in children diagnosed with ASD. Risk factors such as age (25-27), sex
(27-31), subtype of ASD, and IQ score (verbal and non-verbal) have been
suggested, but studies have shown conflicting results for each (32). Looking into
these different risk factors as a possible cause for increased anxiety would lead
to better and more accurate treatments.
Co-occurrence of Anxiety Disorders in Children with ASD
Anxiety disorders have been shown to be the leading source of additional
symptoms in ASD with estimates of comorbid anxiety symptoms as high as 84%
(1), and 2.6 times more common than in children without ASD (7). Patients with
ASD and comorbid anxiety have an increased risk at having behavior disorders
compared to patients with ASD alone (25), difficulties establishing relationships
with friends and family, difficulty sleeping, disrupting family functioning (33, 34),
and social avoidance (35) when compared to youth with ASD alone. Youths
experiencing both ASD and anxiety have a reported increased disruptive
behavior in class, noncompliance with teacher’s demands and disinterest in
peers and peer-centered activities (36-39). Adolescents with ASD have been
found to suffer from anxiety disorders at a higher rate when compared to
externalizing disorders such as Attention Deficit/ Hyperactivity Disorder (ADHD;
(40))
A meta-analysis evaluating 31 studies examining co-occurrence of
conditions suggested that 39.6% of children with ASD had at least one
Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV)
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anxiety disorder, and found that children with ASD have higher anxiety levels
when compared to typically developing children (41). Mean age was found to be
a significant moderator for anxiety for rates of several anxiety disorders, including
generalized anxiety disorder (GAD; Z = 11.94, p < .001) and separation anxiety
disorder (Z = 6.807, p < .001). Studies that had a higher mean age was found to
report higher prevalence rate of anxiety in general and GAD. IQ was also found a
significant moderating effect for rates of anxiety disorders such as separation
anxiety disorder (Z = 5.873, p <.001). A longitudinal study found that a higher
number of anxiety symptoms increases the risk of social communication
impairment over time in children with ASD (β = .22, p =.008: (42)).
Misclassification of co-occurring ASD and anxiety is plausible, as many of
symptoms of ASD (such as repetitive behaviors, communication deficits) are
shared with anxiety disorders (43). There is currently no established method to
reliably diagnose anxiety in children with ASD. Psychiatric diagnostic interviews
have not been established as a reliable tool. The diagnosis of ASD from the
DSM-IV does not measured traditional anxiety levels, which could lead to a
missed diagnosis of anxiety from mislabeling anxiety symptoms as only ASD
symptoms. There is a lack of distinction of symptomology resulting in
opportunities to evaluate screening instruments for the co-diagnosis of these
disorders, leading to better treatment options for patients.
Previous Studies Linking Anxiety Disorders and ASD
White et al. published a meta-analysis on anxiety in children with ASD (1).
With a total of 38 studies being reviewed, the proportion of children with ASD
9

experiencing with some degree of anxiety ranged from 11% to 84%. DeBruin et
al. (44) and Siminoff et al. (45) both looked specifically at the diagnosis of mental
anxiety disorders in children with ASD, finding 55% and 42% of criteria met for
anxiety disorders respectively.
Joshi et al. assessed the difference of diagnosis of anxiety in children with
ASD compared to those not diagnosed with ASD (46). With a total sample size of
N = 2,323 (n = 217 diagnosed with ASD) a significant difference in the diagnosis
of multiple anxiety disorders (ASD = 61%, non-ASD = 42%, p < .001) and GAD
(ASD = 35%, non-ASD = 30%, p < .001) was observed between the study
groups. However, there was no significant difference observed between
separation anxiety disorder (ASD = 37%, non-ASD = 35%, p = .84) and panic
disorder (ASD = 6%, non-ASD = 8%, p = .35).
Screening Tools for Anxiety in Children with ASD
Kaat and Lecavalier in 2015 studied the reliability and validity between
parent and child rated anxiety measures in children with ASD (47). The
researchers used the Autism Diagnostic Observation Schedule-Second Edition
(ADOS-2) to assess for specific social behaviors (48). The Wechsler Intelligence
Scales for Children-Fourth Edition (WISC-IV) was used as a standardized
measure of intelligence of children ages 6 to 16 (49). The Revised Children’s
Anxiety and Depression Scale (RCADS) (50) and the Multidimensional Anxiety
Scale for Children (MASC-2) (51) were both completed by the children and
parents to measure anxiety disorders. With a population of 46 children with
parents between the ages of 8 and 16 years (mean 12.4, SD:2.3 years), Kaat
10

and Lecavalier found that the reliability for the RCADS and MASC-2 were .82 (p
< .001) and .83 (p <.001), respectively.
There is no clinical assessment tool that is agreed upon to be the gold
standard in accessing anxiety in ASD patients, leaving a gap in the literature
(52). Previous studies have examined the predictive ability of the parent- and
child-reported versions of the SCARED compared to other autism screening tools
such as the ASEBA scales, the Child Behavior Checklist (CBCL), and the Youth
Self-Report (YSR; (53)). However, no studies have evaluated the correlation and
association between the SCARED and SRS scales.
Screen for Child Anxiety-Related Emotional Disorders (SCARED)
The Screen for Child Anxiety-Related Emotional Disorders (SCARED) is
used to screen for anxiety in youth (54). The SCARED is a 41-item parent and
child-report scale that screens for anxiety in youth, and shows good internal
reliability and convergent validity with clinical structured interviews in children
with ASD (55). Both versions of the SCARED are broken down into 5 subscales,
which includes: Panic Disorder or Significant Somatic Symptoms (“When I get
frightened, I feel like passing out” -child, “When my child feels frightened, it is
hard for him/her to breathe” -parent), GAD (“I worry about being as good as other
kids” -child, “My child is a worrier” -parent), Separation Anxiety SOC (“I have
nightmares about something bad happening to me” -child, “My child is afraid to
be alone in the house” -parent), Social Anxiety Disorder (“I feel nervous with
people I don’t know well” -child, “It is hard for my child to talk with people he/she
doesn’t know well” -parent), and Significant School Avoidance (“I am scared to
11

go to school” -child, “My child gets stomachaches at school” - parent). The
SCARED uses a 3-point Likert-scale, translating to a total score range of 0 to 82.
A total score of 25 or higher on the SCARED indicates the presence of an
anxiety disorder in a child, with scores higher than 30 being more specific.
Parents generally report more anxiety than children using this scale, with a mild
correlation shown (56).
Previous Studies Evaluating the SCARED Instrument
Wigham and McConachie also investigated the structure and reliability of
the SCARED instrument (57). A total 63 different articles were included, with a
total of eight measurement tools for diagnosing ASD concluded that the
SCARED instrument has good internal reliability (α = .93) with evidence of testretest reliability for both total scores and subscores (α = .86;(58)) between the
two scales. A moderate correlation between the parent- and child- reported
scales (r = .20 to r = .47, p < .001), with a correlation of r = .33 (p < .001) in
children with ASD was reported. The SCARED has also been shown to be a
valid measure of anxiety in children with autism by being cross-validated with the
Achenbach System of Empirically Based Assessment Scales (ASEBA; (53)). The
association of demographic variables (race, age, sex) to the child-reported
SCARED score has also been studied, with only the sex of the participant being
significant (β = 12.2, SE = 4.5, p = 0.008; (53)). This beta suggests that the childreported SCARED score is 12 points higher if the child is female compared to
male.
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DeSousa et al., examined the sensitivity and the specificity of the
SCARED instrument in a population of 119 students aged 9-18 years (mean =
12.66, SD = 2.32) (59). Forty-four participants (37%) had at least one anxiety
disorder, with 26 having GAD (21.8%), 24 having social phobia (20.2%), and 9
having separation anxiety disorder (7.6%). Results showed that the SCARED
had a sensitivity of 81.8% and a specificity of 52.0% regarding any anxiety
disorder. These results suggest that the SCARED is a useful instrument for the
screening of anxiety disorders, both in general and for specific anxiety disorders.
Reaven et al., studied the SCARED and its ability to reliably measure ASD
in children with at least one anxiety disorder (60). Following 50 children with ASD
and anxiety disorder in a cognitive behavior therapy (CBT) for a 12-week period,
Reaven found that scores on the SCARED were reduced by 34% in the CBT
groups. This result was significantly better than the 6% reduction in the control
group, supporting that the SCARED is an outcome measure to children with
ASD. Given the small sample size of this study, additional studies need to be
made to have full confidence in these results.
Stern et al., also looked at the psychometric characteristics of the
SCARED in children with ASD seeking treatment for anxiety disorders (56).
Results showed that the SCARED has good internal consistency for both the
parent and child reports of the survey, with a Cronbach’s alpha of .90 on the
parent report and a .92 for the child report. The parent report on the GAD
subscale was significantly higher (mean = 11.78, SD = 3.95) than the children
report ((mean = 9.93, SD = 3.91), F (1, 114) = 5.54, p = .020). Parents also had a
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total higher score on the SCARED (mean = 36.42, SD = 14.87) than the children
((mean = 31.11, SD = 11.61), F (1, 104) = 3.98, p = .049). From these findings,
Stern et al. suggest that the SCARED “is a valid and clinically useful tool for
assessing anxiety in treatment-seeking children and adolescents with ASD” ((56);
page 7).
Social Responsiveness Scale (SRS)
The Social Responsiveness Scale (SRS) is used to measure social and
autistic behavior in 4 to 18 year-olds (61). The SRS is a 65-item parent/teacher
questionnaire that can be completed in 15-20 minutes. The SRS can be broken
into 5 subcategories, which include: Social Awareness (“Is aware of what others
are thinking or feeling”), Social Cognition (“Takes things too literally and doesn’t
get the real meaning of a conversation”), Social Communication (“Is able to
communicate his or her feelings to others”), Social Motivation (“Seems selfconfident when interacting with others”), and Autistic Mannerisms (“Behaves in
ways that seem strange or bizarre”). The SRS uses a 4-point Likert-scale and
has a total range of scores from 0 to 195. Total raw scores can be transformed
into T scores with a higher score indicating a higher tendency for the child to
exhibit autistic behaviors in a social setting.
Previous Studies Evaluating the SRS
Duvekot et al., studied the sensitivity and specificity of the SRS in a
population of 596 children aged 4-10 years (62). Devekot implemented a twophase design (63), which oversampled children who screened positive on the
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SRS in an ASD-specific diagnosis. A total of 4,344 children were sent the SRS,
with a total of 1,182 completed reports returned. Of the total 596 children, 393
screened positive (total score of ≥75 on the parent report), and 203 children who
were randomly selected from the 789 children who screened negative. With the
cutoff of 75, the SRS resulted in a sensitivity of .85 and specificity of .83,
suggesting that the SRS is good at predicting children with autistic behaviors.
Cholemkery et al., looked at the validity of the SRS, and its ability to
differentiate between ASD and other disruptive behavior disorders in 165 children
aged 6-18 years (64). Cholemkery et al., recruited a total of 55 individuals with
ASD, 55 individuals with oppositional defiant disorder (ODD) and conduct
disorder (CD), and 55 individuals with typical development (TD) as controls. The
highest results on the SRS was found in individuals with ASD (mean = 97.0, SD
= 26.7), followed by ODD/CD (mean = 59.1, SD = 12.9), with the TD group
scoring the lowest (mean = 19.4, SD = 12.9). The group differences on the SRS
was statistically significant (F/χ2 = 42.22, df = 2, p < .0001).
Azad et al., examined the concordance of parents and teachers
completion of the SRS for children with ASD (65). A total of 123 parents and
teachers took the SRS at the beginning and the end of each school year for two
school years for the appropriate child. The parents and teachers had a significant
agreement on SRS total scores at the beginning (r = .28, p = .005) and end (r =
.47, p < .0001) of each school year. At the beginning of the school year, there
was a statistically significant correlation between parents and teachers in each of
the SRS subscales, with an exception to autistic mannerisms (r = .16, p = .13). At
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the end of the school year, there was a statistically significant agreement
between parents and teachers in each of the SRS subscales. For less severely
ASD affected children, there was no statistically significant correlation in SRS
scores at either the beginning (r = .14, p = .48) or end (r = .14, p = .46) of the
school year.
Aldridge et al., evaluated the ability for the SRS to accurately predict a
diagnostic outcome of ASD to a tertiary level (66). ASD was defined using the
Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition, Text
Revision (DSM-IV-TR) (67), and information gathered from background reports of
previous cognitive assessments and/or current academic functioning. Forty-eight
children ages 4 to 15 years (mean = 8.83, SD = 2.58) were given the SRS before
being accessed for ASD. Results show that the SRS had a high sensitivity (91%
parent report, 84% teacher report), but had a considerably lower specificity (8%
parent report, 41% teacher report).
Murray et al., also examined the SRS’s ability to predict autism in children
(68). Murray et al., looked at a population of 29 adolescents of 12- 17 years
(mean = 14.5, SD = 1.5) who are suspected of having ASD, by giving them both
the SRS and Autism Diagnostic Interview-Revised (ADI-R; (69)). Of these 29
adolescents, 25 had an SRS score at or above the cutoff point of 75, with 4
having an SRS score lower than the cutoff point. With 86.2% of the population
scoring at or above the cutoff point of 75, the SRS has been shown to be a good
predictor of ASD in adolescents.
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Biological Mechanisms for the Co-occurrence of ASD and Anxiety
Previous studies have shown that the amygdala is smaller in patients with
both autism and anxiety when compared to those with autism alone (70). The
amygdala is the primary part of the brain with the role of perception, encoding,
and retrieval of emotional information, and has been widely implicated in ASD
(71), and is hypothesized to have a decreased volume in ASD patients suffering
from anxiety due to excitotoxicity. The increased activity can lead to degradation
of the cellular architecture and cell death of that section of the brain. Black
mon et al. hypothesized that increased usage of the amygdala due to anxiety
caused degradation of gray matter (72). Herrington et al. found that the right
amygdala from a sample of adolescents with both autism and anxiety had a
significantly decreased volume when compared to adolescents with ASD alone
(p = .04), while finding that the total brain volume is not significantly different (p =
.08; (70)).
Another explanation that has been proposed from previous studies is that
abnormalities of serotonin 5-hydroxyindoleacetic acid (5-HT) can represent a
causal link in autism and anxiety (30). Studies have shown that the
developmental process of serotonin synthesis in the brain is disrupted in children
with ASD between the ages of 2 and 15 years, causing impulsive symptoms,
repetitive movements, and social features (73-75). Decreased levels of serotonin
has also been shown to increase the risk of anxiety (76).
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Another possible explanation that have been suggested is the difficulty
children with autism and anxiety have in processing diverse sources of
information, causing these children to experience these everyday interactions as
chaotic and freighting (77).
Summary
A review of the literature has shown a difficulty in traditional face-to-face
diagnosis of co-occurring ASD and anxiety in adolescents. While the literature
has begun to look at the predictability of instruments measuring anxiety in
children with ASD, there is no gold standard of co-diagnosis. Previous studies
have shown a predictive ability of the SCARED with ASD diagnostic instruments
such as the ASEBA (53). However, there has not been a study that has looked at
the correlations between both versions of the SCARED and the SRS, nor has
there been a study that has looked at these different demographic variables and
their effect on the association between the SCARED and SRS, leaving a gap in
the literature.
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MATERIALS AND METHODS

Study Population
This study was conducted using data collected from Lohr et al. and
methods have been previously described (53). In brief, the Bingham Clinic is a
general child psychiatry clinic with referrals from providers, families, and inpatient
units. The Weisskopf Child Evaluation Center provides diagnostic evaluations for
children with possible developmental disabilities, genetic disorders, autism,
ADHD, and other learning disabilities. The University of Louisville Autism Center
provides diagnostic evaluations of autism, conducts clinical research of ASD, and
provides training for caregivers and educators working with these children. To
recruit participants, referrals were obtained from posted notices to the Bingham
Clinic, the Weisskopf Child Evaluation Center, and the University of Louisville
Autism Center, along with treating clinicians in clinics. Participants and their
parents completed demographics and questionnaires during their next clinic visit
or at a scheduled appointment. It took both participants and their parents about
an hour to complete the questionnaires. Cases were ascertained from July 2013
through December 2014. Inclusion criteria include adolescents aged 8 to 18
years who have an established clinical diagnosis of high-functioning autism to
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limit possible response bias and were able to read and complete the
questionnaires without any assistance. Missing data was addressed through
contacting family members to fill in missing question items.
A total of 100 patients were recruited, 88 males and 12 females, aged 818 years (mean = 12.9 years, SD = 2.8 years). Eighty-eight of the subjects selfidentified as Caucasian. Sixty-four of the subjects were diagnosed with ASD with
a psychological test including the use of the Autism Diagnostic Observation
Schedule (ADOS). The other thirty-six subjects were diagnosed with ASD by
trained clinical professionals according to the DSM-IV and DSM-5 criteria. Eighty
seven percent of the subjects had at least one comorbid psychiatric disorder,
with anxiety disorder being the most common (n = 70). All comorbid diagnoses of
the study population were obtained from the subject’s medical records. All
participants and their families completed informed consent as approved by the
University of Louisville IRB.
Predictor
The SCARED was used to screen for anxiety in youth. The SCARED has
a total range of scores ranging from 0 to 82, with scores higher than or equal to
25 reflecting a more specific screen for at least one anxiety disorder, as per
suggested by Birmaher et al. (58). Individual questions will be entered as a
continuous variable, with responses of 0 = “never true”, 1 = “sometimes true” and
2 = often true”.
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Outcome
The SRS was used to screen for autistic tendencies in adolescents. The
SRS has a total range of scores ranging from 0 to 195. The total score will be
converted into a dichotomous variable, severe range of diagnosis of ASD and
mild to moderate range of diagnosis of ASD. For the purposes of this study, a
screening in the severe range of diagnosis (≥87) will be considered a positive
screening, and a screening in the mild to moderate range (≤86) will be
considered a negative screening. These cut offs will be based on
recommendations given by Constantino et al. (61).
Other Variables
Race was converted into a dichotomous variable of White and non-White.
Age was self-reported and was collected at the completion of the questionnaires
for Lohr et al. (53). Age group was broken into 8-10 years, 11-13 years, and 1418 years to reflect the break between school levels (elementary, middle, and high
school) in the public and private schools of Jefferson County. Sex was selfreported as either being male or female.
Data Analysis Procedure
We started with a raw data set of N = 100 with demographics and multiple
self-reporting surveys. This raw data set was reduced to only include only the
age, sex, race, total SRS score, total SCARED parent, and child score, and both
the parent and child responses to the SCARED. This data set was further broken
into two separate data sets that either included the parent or the child responses
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to the SCARED, along with the corresponding total SCARED scores. For each of
these separate datasets, participants were deleted for having missing data in any
response options of the SCARED. A total n = 6 was deleted from the parent
sample, leaving N = 94, and a total n = 11 was deleted from the child sample,
leaving N = 89.
Statistical Methods
Statistical analysis was performed using R v. 3.4.2. The correlation
between both total scores of the parent- and child-version of the SCARED
compared to a positive screening on the SRS was assessed using the pointbiserial correlation method (78). The parent-reported SCARED and childreported SCARED was assessed using the Pearson correlation method (79).
These methods gives an r statistic, which explains the total correlation between
the two variables, ranging from -1 to 1. These associations were measured as 0
to 0.3 as a weak association, 0.3 to 0.7 as a moderate association, and 0.7 to 1.0
as a strong association (80).
The analysis of the ability of the SCARED to accurately predict scores of
the SRS was completed using penalized logistic regression, utilizing the Least
Absolute Shrinkage and Selection Operator (LASSO) regression (81). LASSO
regression is a method used in conjunction with logistic regression, and the
LASSO takes the sum of the absolute values of the coefficients found using
logistic regression to be less than a fixed value, forcing some variables to
approach zero, effectively removing these variables from the model. This method
can make the resulting model simpler and easier to interpret. This penalty
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regression model has been shown to be an effective device for models where the
number of predictors is similar to or exceeds the number of observations (81,
82). The LASSO regression model gives a greater prediction accuracy along with
a lower bias in the model when compared to traditional regression methods in
models with a large number of variables.
The initial cross-validation model of the LASSO regression will find the
optimal tuning parameter (λ) of the model. The cross-validation model will select
the tuning parameter using the mean-squared error to predict the maximum
value for the sum of coefficients. The tuning parameter chosen was the lambda
value that is the most regularized within one standard deviation of the minimum
error as determined by the model. The selected tuning parameter gave best fit of
the model by setting a limit to the level of shrinkage in the model. This selected
tuning parameter was used in a second model that will select the optimal subset
of variables for predicted a positive screening of the SRS. The data was also
standardized to address differently scaled predictors, and to ensure the proper λ
will be calculated from the model.
With the resulting model from the LASSO regression, a logistic regression
model was made using the items in the SCARED that were identified as
significant in predicting the SRS. The lambda value that produced the most
regularized model within one standard deviation of the lambda value that
produced the minimum mean-squared error will be used, as per the suggestions
by Krstajic et al. (83). An odds ratio (OR) and 95% Confidence Intervals (CI) was
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produced for each item, explaining whether the odds of a positive screening of
the SRS occurred given the score from a selected item from the SCARED.
To evaluate the effects of a child’s age group, sex, and race on the
association of both the parent- and child- versions of the SCARED and the SRS,
unconditional logistic regression was used. Each potential confounder was taken
out of each model to find the most parsimonious model that gave the closest
result to the crude model. This was achieved by selecting the model that
reflected the most similar ORs when compared to the crude model. An OR and
95% CIs was produced for each demographic, explaining the odds that a positive
screening of the SRS will occur given the specific demographic characteristic.
The referent group for race was White, for sex was male, and age-group was
entered as a continuous variable (8-10 years, 11-13 years, 14-18 years).
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RESULTS

Descriptive Results
Majority of the sample was male (88%), between 11 to 13 years of age
(44%) with 88% percent White (Table 1). A majority suffered from two (34%) or
three (28%) different psychiatric disorders, with anxiety disorder (70%) and
ADHD (66%) being the most common.
A majority of the population had a positive screening on the SRS, which
indicates a severe range of diagnosis for ASD. The age group with the highest
positive screening were those ages 14-18 years (80.8%) A higher proportion of
males had a positive screening compared to females (75% vs. 66.7%), as well as
those who self-reported White race compared to non-White race (75% vs. 60%).
Positive screening data was not available for these analyses including comorbid
diagnosis and type of psychiatric disorder.
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Table 1: Demographic Characteristics of Study Sample (N = 100)
Variables

Frequency

Positive SRS
Screening (%)

8-10

30

20 (66.7)

11-13

44

33 (75.0)

14-18

26

21 (80.8)

Male

88

66 (75.0)

Female

12

8 (66.7)

White

88

66 (75.0)

Non-White

10

6 (60.0)

Zero

13

-

One

22

-

Two

34

-

Three or More

31

-

Type of psychiatric
disorder
GAD

70

-

ADHD

66

-

OCD

15

-

Major depression

12

-

Impulsive control disorder
NOS
Mood disorder NOS

8

-

6

-

PTSD

5

-

Oppositional defiant
disorder

4

-

Age Group (years)

Gender

Race

Comorbid diagnosisa

ADHD, Attention Deficit Hyperactivity Disorder; GAD, Generalized Anxiety Disorder; NOS, Not
otherwise specified; OCD, Obsessive Compulsive Disorder; PTSD, Post-Traumatic Stress
Disorder
a Number of psychiatric disorders diagnosed in total
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The average total score on the SRS was 110.48 (SD ± 29.20; range 53 176) (Table 2). A total of 74 participants had a severe range of ASD diagnosis
with total scores greater than or equal to 87, as per suggested by Constantino et
al. (61). The highest average total score on the subscales was for Social
Communication (37.28, SD ± 10.94), followed by Autistic Mannerisms (21.87, SD
± 7.14) and Social Cognition (20.73, SD ± 6.47). Social Communication has the
highest subscore due to the fact that it has the most questions in the instrument,
and did not have the highest average score per question (1.69) between each
subscale.
The average total of the child-reported SCARED was 27.06 (SD ± 15.88;
range 2 - 63) (Table 2). A total of 52 participants had significant total score with
greater than or equal to 25, as per suggested by Birmaher et al. (54). The highest
average total score on the subscales was for GAD (7.08, SD ± 0.57), followed by
Panic Disorder (6.47, SD ± 0.54) and Social Anxiety Disorder (6.40, SD ± 0.52).
GAD was the highest subscore due to a higher average score per question
(0.79), making it the highest contributor to the total score of the SCARED.
The average total of the parent-reported SCARED was 28.49 (SD ± 13.85;
range 5 - 60) (Table 2). A total of 55 participants had a significant total score with
greater than or equal to 25, as per suggested by Birmaher et al. (54). The highest
average total score on the subscales was for GAD (8.63, SD ± 0.22), followed by
Social Anxiety Disorder (7.13, SD ± 0.29) and Panic Disorder (5.54, SD ± 0.26).
GAD was the highest subscore due to a higher average score per question
(0.96), and also had the highest participants with a significant score in the
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subscore (51); this subscale may be a notable contributor to symptoms when
compared to other subscales.
Table 2: Instrument Total Scores
Instrument

SRS

Subscale (# of

Total Score

Average

Significant

Questions)

SD

score/question

score (n)

Total Score (65)

110.48 ±

1.70

74

Social Awareness (8)

13.14 ± 3.75 1.64

49

Social Cognition (12)

20.73 ± 6.47 1.73

73

Social

37.28 ±

1.69

79

Communication (22)

10.94

Social Motivation

16.78 ± 5.81 1.53

54

21.87 ± 7.14 1.82

93

27.06 ±

0.66

38

29.19

(11)
Autistic Mannerisms
(12)
SCARED

Total Score (41)

(Child)

15.88
Panic Disorder (13)

6.47 ± 5.71

0.50

41

Separation Anxiety

5.23 ± 3.52

0.65

54

6.40 ± 4.24

0.91

31

School Avoidance (4) 2.38 ± 2.07

0.60

42

Total Score (41)

0.69

42

(8)
Social Anxiety
Disorder (7)

SCARED
(Parent)

28.49 ±
13.85

Panic Disorder (13)

5.54 ± 5.14

0.43

30

Generalized Anxiety

8.63 ± 4.57

0.96

51

Disorder (9)

28

Instrument

Subscale (# of

Total Score

Average

Significant

Questions)

SD

score/question

score (n)

Separation Anxiety

4.72 ± 3.60

0.59

47

7.13 ± 4.18

1.02

41

School Avoidance (4) 2.48 ± 2.31

0.62

43

(8)
Social Anxiety
Disorder (7)

Correlation between the parent- and child-reported of the SCARED and the
SRS
A moderate, statistically significant correlation between the parentreported of the SCARED and a positive screening of the SRS (r = 0.399, p =<
0.001) was observed. A weak, non-significant correlation was found between the
child-reported of the SCARED and a positive screening of the SRS (r = 0.105, p
= 0.300). A moderate, statistically significant correlation was found between the
parent- and child- reported of the SCARED (r = 0.447, p = <0.001).
Predictive ability of the SCARED on positive screening of the SRS via
LASSO regression
The cross-validation of the LASSO of the child-reported SCARED (N = 89)
produced lambda value with the lowest mean-squared error of 0.100. This
lambda value was used to help identify the tuning parameter λ for the LASSO
regression model, but a lambda that was most regularized within one standard
error was not reported. The most regularized lambda value is used for this model
to prevent overfitting of the model to the dataset. Figure 1 shows the cross-
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validation results of the child-reported SCARED. Each bar shown in Figure 1 is a
lambda value and 95% CI for the mean-squared error used in each iteration of
the LASSO model, with the dotted line signifying the lambda value that gives the
minimum mean-squared error in the cross-validation model. The top axis of
Figure 1 explains how many questions of the SCARED are left in the model at
each lambda value. With no optimal lambda value found from the crossvalidation model, this suggests that the most regularized lambda value is the
model nearest to a lambda value of 0. This result suggests that there is no
optimal lambda value for this data, which can be due to insufficient sample size
and limited statistical power to detect an association. The LASSO regression
analysis resulted in none of the questions in the child-reported SCARED having a
significant predictive ability of a positive screening on the SRS. The five
questions with the largest lambda values before being dropped from the model
are shown in Table 3.
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Figure 1: Cross-validation of the child-reported SCARED

The cross-validation of the LASSO of the parent-reported SCARED (N =
94) produced a lambda with the lowest mean-squared error of 0.062, and found
the most regularized lambda within one standard deviation of the minimum as
0.157. Figure 2 shows the cross-validation results of the parent-reported
SCARED. Each bar shown in Figure 2 is a lambda value and 95% confidence
interval used in each iteration of the LASSO model. The left most dotted line
signifies the lambda value that gives the minimum mean-squared error in the
cross-validation model, while the right most dotted line signifies the lambda value
that produces is the most regularized model that is within one standard error of
the minimum error model. The top axis of Figure 2 explains how many questions
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of the SCARED are left in the model at each lambda value. The LASSO
regression resulted in the ninth (“People tell me that my child looks nervous”) and
thirty-seventh (“My child worries about things that have already happened”)
question on the SCARED having a significant ability to predict a positive
screening on the SRS. The five questions with the largest lambda values before
being dropped from the model are shown in Table 3.
Figure 2 Cross-validation of the parent-reported SCARED
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Table 3: Largest Lambda Values via the LASSO
SCARED instrument

Question #

Lambda value

Child

1

0.088

5

0.073

6

0.100

25

0.073

30

0.067

1

0.115

9*

0.172

11

0.088

19

0.074

37*

0.159

Parent

* Indicates significant predictability

Both question 9 (“Child looks nervous”) and question 37 (“Child worries
about things”) were found to have a significant association with a positive
screening of the SCARED when each question is put into the model individually
and when each question is put into the same both logistic models (Table 4).
Crude analysis shows that “Child looks nervous” of the parent-reported SCARED
has a significantly higher odds of predicting a positive screening on the SRS, OR
= 1.278 (95% CI = 1.144 – 1.429). Entered as a continuous variable, going from
“not true” to “sometimes true” and “sometimes true” to “often true”, there is a
27.8% increase in the odds that a patient will have a positive screening on the
SRS. This is also when going the opposite way from “often true” to “sometimes
true” to “not true. “Child worries about things” of the parent-reported SCARED
also has a significant ability to predict a positive screening on the SRS, OR =
1.232 (95% CI = 1.113 – 1.364). Entered as a continuous variable, going from
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“not true” to “sometimes true” and “sometimes true” to “often true”, there is a
23.2% increase in the odds that a patient will have a positive screening on the
SRS. This is also when going the opposite way from “often true” to “sometimes
true” to “not true.
Table 4: Assessment of Variables and Screening Positive on SRS
SCARED Question

Crude OR (95% CI)

“Child looks nervous”

1.278 (1.144 – 1.429)

“Child worries about things”

1.232 (1.113 – 1.364)

Associations between the child- and parent-reported of the SCARED and
SRS when stratified by demographics
The relationship between “Child looks nervous” and “Child worries about
things” from the parent-reported SCARED and a significant screening of the SRS
was modeled including age, race, and sex. No collinearity was found in a model
containing both “Child looks nervous” and “Child worries about things” (variance
inflation factor = 1.175). No interaction term was found to be significant in the
model (lowest p-value age*race: 0.334), thus none were entered into the final
model.
Models containing age, race, and sex were completed, resulting in crude
OR = 1.199 (95% CI = 1.067 – 1.347) for “Child looks nervous” and OR = 1.190
(95% CI = 1.070 – 1.324) for “Child worries about things”. The model containing
age and sex gave the most parsimonious model that fit closest to the crude
model (age “Child looks nervous”: OR = 1.288 [95% CI = 1.142 – 1.399], “Child
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worries about things”: OR = 1.264 [1.142 – 1.387], sex “Child looks nervous” OR
= 1.199 [1.069 – 1.345], “Child worries about things”: OR = 1.186 [1.067 –
1.317]), and was used for further analysis (Table 5).
Table 5: Breakdown of Model Selection
“Child looks nervous”

“Child worries about things”

OR (95% CI)

OR (95% CI)

Age/Race/Sex

1.199 (1.067 – 1.347)

1.190 (1.070 – 1.324)

Age/Race

1.207 (1.074 – 1.356)

1.181 (1.062 – 1.313)

Race/Sex

1.196 (1.137 – 1.429)

1.165 (1.046 – 1.297)

Age/Sex*

1.199 (1.069 – 1.345)

1.186 (1.067 – 1.317)

Age

1.207 (1.076 – 1.354)

1.175 (1.058 – 1.304)

Race

1.201 (1.066 – 1.352)

1.161 (1.043 – 1.292)

Sex

1.197 (1.064 – 1.347)

1.160 (1.043 – 1.291)

None

1.202 (1.069 – 1.351)

1.156 (1.040 – 1.285)

Model

* Model used in analysis
Age was found to have a significant association between “Child looks
nervous” and “Child worries about things” and a significant screening on the SRS
(OR = 1.141 [95% CI = 1.027 – 1.268]) (Table 6). These results suggest that an
increase in age group will have 14.1% higher odds to have a positive SRS
screening from “Child looks nervous” and “Child worries about things” of the
parent-reported SCARED compared to children in lower age groups. Sex was not
found to be significant association between “Child looks nervous” and “Child
worries about things” and a significant screening on the SRS (OR = 0.853 [95%
CI = 0.670 – 1.084]). If significant, these results would suggest that females have
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a decrease of 14.7% odds of finding a positive screening on the SRS from “Child
looks nervous” and “Child worries about things” of the parent-reported SCARED.
Table 6: Most Parsimonious Model for Assessment of Demographics
Model

OR (95% CI)

“Child looks nervous”

1.199 (1.069 – 1.345)

“Child worries about things”

1.186 (1.067 – 1.317)

Sex

0.853 (0.670 – 1.084)

Age

1.141 (1.027 – 1.268) *

* Indicates significance
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DISCUSSION

This is the first known report of comparing the SCARED and its ability to
predict a positive screen for ASD using the SRS instrument, and illustrates
crucial information on how anxiety and autism co-occur and how they are
perceived by children and parents.
The parent-reported SCARED was significantly correlated with the childreported SCARED and significant score on the SRS; however a significant
correlation between the child-reported SCARED and significant score on the
SRS was not found. These results could be explained as parents interpreting
externalized behaviors as anxiety, per suggested by Lohr et al. (55). The SRS
was completed only by parents, and could result in a tendency to answer similar
questions identically.
Logistic regression analysis via the LASSO showed there was no
significant association between the child-reported version of the SCARED and a
positive screening of ASD using the SRS instrument. There was a significant
association between question nine and question thirty-seven of the parentreported version of the SCARED to a positive screening of the SRS.
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Sex and age were tested to have significant predictability of the
association between these SCARED questions and a positive screening of ASD
using the SRS instrument. Logistic regression models showed age as being a
predictor of this association, meaning older children are more likely to have a
positive screening on the SRS from question nine and thirty-seven of the parentreported SCARED. Previous studies report age as a significant risk factor on the
co-occurrence of autism and anxiety (25, 26). This relationship could be
explained by delayed development of cognitive and motor functions and the
ability to express anxiety symptoms until later ages, as suggested by Davis et al.
(26). Another possible explanation to this relationship is to the effects of public
school and increasing anxiety symptoms in children with ASD compared to
children with ASD who are home schooled due to the severity of the disorder.
Sex was not found to significantly predict the association between these
SCARED questions and a positive screening of the SRS. This result contradicts
previous studies looking at anxiety in children with ASD (29,30), while supporting
the results of other studies (28,30,31). This could possibly be explained by
shared neurobiological dysfunctions in both boys and girls with ASD having an
overriding effect on psychopathology, resulting in the effects of anxiety levels
being similar in boys and girls, as suggested by Brereton et al. (84). The small
sample size of twelve females in the population could lead to an inability to detect
a significant difference in the analysis.
Previous studies found as high as 84% co-occurrence of ASD and anxiety
disorders in children, similar to the 87% of co-occurrence found in this study (1).
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Higher correlations were found in the parent-reported SCARED to positive
screenings of autism from the SRS compared to findings from the child-reported
SCARED to positive screenings of autism, showing similar conclusions gathered
from other studies (53, 56, 57). Similar significant predictability of co-occurrence
in anxiety and ASD was found in studies using a different instrument (30, 41, 47),
as well as studies using the SCARED (53).
This study was conducted using data using non-stringent clinical
diagnostic procedures, limiting its replicability. Clinical diagnoses were mostly
conducted under the guidelines of the DSM-IV, but has been noted as to still
diagnose social communications, allowing for the SCARED to yield clinically
useful information (53). This population comes from a local psychiatry clinics,
thus limiting the generalizability to the community at large.
Strengths and Limitations
There are several strengths to this study. This study is the first of its kind
to look at the predicative abilities of both the parent-reported and child-reported
versions of the SCARED for a significant score on the SRS. Each of these are
validated and standardized measures, with each shown to be a valid measure in
children with both anxiety and autism. The primary author of Lohr et al. (53)
reviewed all diagnoses, along with review of school records prior to participation
in the study. While there is no gold standard for co-diagnosis of these disorders,
this study gives more information into how a correct co-diagnosis can occur,
allowing for more precise treatments. All patients in the population are
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considered to have high-functioning autism, suggesting that patients are more
likely to understand and properly answer questionnaires, limiting response bias.
This study is the first to utilize a novel method, LASSO regression, to
predict the outcomes of one instrument from the scores on another instrument.
Utilizing this once never used method gave a new look at the predictive abilities
of instruments with a similar number of questions to number of participants.
Using penalty regression methods, such as LASSO, can yield a wealth of new
information, such as reliable predictability in populations of rare diseases with
high levels of possible predictors, and should be used in future studies looking at
predictive abilities of instruments.
This analysis has several limitations that require consideration. It was
difficult to detect a significant predictive ability due to the small sample size.
While no significant effects were found from the child-reported SCARED and only
two found from the parent-reported SCARED, this analysis adds new and
relevant data to the literature. Missing data limited the overall numbers that were
used for the analysis.
Data for the child- and parent-reported SCARED were reported as
continuous variables, causing possible cofounding of demographics to possibly
be missed. The analysis of only two of the possible forty-one items of the parentreported SCARED could limit the overall predictability of the instrument, and
exclude possible items that have a significant predictability of autism from the
SRS instrument.
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Another limitation to address is the possibly of missing confounders by
unmeasured measures (e.g., type of schooling, genetic factors, depression). The
population only included n = 12 females and non-White patients, limiting the
ability to draw conclusions.
This population comes from local psychiatry clinics, thus limiting the
generalizability to the community at large. Each clinical diagnosis was preexisting according to DSM-IV and DSM-5 criteria. A possible limitation from
variability in diagnoses of across multiple clinics and physicians could lead to
anchoring or confirmation bias. This could have an effect on the estimates as
some patients in the population might be misclassified as having ASD or having
an anxiety disorder. Most patients were diagnosed under the DSM-IV criteria, but
has been noted as to still diagnose social communication, allowing for the
SCARED to yield clinically useful information (53).
Conclusion
This study is the first to evaluate the predictive ability of the SCARED to
the SRS, along with being the first study to examine the ability of the LASSO to
identify the predictive abilities of one instrument to another. Although conducted
with a small sample, two questions from the parent-reported SCARED were
found to have a significant predictive ability of a significant score on the SRS.
Future research using a larger sample and inclusion of possible confounders,
such as genetic factors, schooling, and other co-occurring disorders will expand
the knowledge between this association, allowing for a more precise estimation
of co-occurring diagnosis, leading to better treatments for patients. Future studies
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may also look at the predictability of the SRS to a positive anxiety screening, and
compare these results to determine if there are similar conclusions.
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